Twist Bioscience Corporation (BIT:1TWST)

Italy flag Italy · Delayed Price · Currency is EUR
29.67
-1.06 (-3.45%)
At close: Jul 21, 2025
-3.45%
Market Cap1.83B
Revenue (ttm)321.67M
Net Income (ttm)-176.85M
Shares Outn/a
EPS (ttm)-3.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Openn/a
Previous Close30.73
Day's Rangen/a
52-Week Range24.58 - 34.57
Betan/a
RSI50.23
Earnings DateAug 1, 2025

About Twist Bioscience

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Employees 923
Stock Exchange Borsa Italiana
Ticker Symbol 1TWST
Full Company Profile

Financial Performance

In 2024, Twist Bioscience's revenue was $312.97 million, an increase of 27.69% compared to the previous year's $245.11 million. Losses were -$208.73 million, 2.01% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.